KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Resmed (RMD) Depreciation & Amortization (IS) (2021 - 2025)

Historic Depreciation & Amortization (IS) for Resmed (RMD) over the last 5 years, with Q4 2025 value amounting to $49.9 million.

  • Resmed's Depreciation & Amortization (IS) rose 742.05% to $49.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $204.9 million, marking a year-over-year increase of 1489.73%. This contributed to the annual value of $198.5 million for FY2025, which is 1221.41% up from last year.
  • Resmed's Depreciation & Amortization (IS) amounted to $49.9 million in Q4 2025, which was up 742.05% from $47.7 million recorded in Q3 2025.
  • In the past 5 years, Resmed's Depreciation & Amortization (IS) ranged from a high of $63.6 million in Q2 2025 and a low of $36.3 million during Q3 2022
  • Moreover, its 5-year median value for Depreciation & Amortization (IS) was $43.7 million (2024), whereas its average is $43.7 million.
  • In the last 5 years, Resmed's Depreciation & Amortization (IS) tumbled by 740.89% in 2022 and then soared by 4567.52% in 2025.
  • Quarter analysis of 5 years shows Resmed's Depreciation & Amortization (IS) stood at $40.8 million in 2021, then dropped by 7.41% to $37.8 million in 2022, then increased by 18.58% to $44.8 million in 2023, then grew by 3.7% to $46.4 million in 2024, then rose by 7.42% to $49.9 million in 2025.
  • Its Depreciation & Amortization (IS) stands at $49.9 million for Q4 2025, versus $47.7 million for Q3 2025 and $63.6 million for Q2 2025.